Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus Vaccines
about
Vaccines within vaccines: the use of adenovirus types 4 and 7 as influenza vaccine vectors.Current progress in the development of a prophylactic vaccine for HIV-1.Characterization of species C human adenovirus serotype 6 (Ad6)Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant.Generation and evaluation of clade C simian-human immunodeficiency virus challenge stocksMolecularly cloned SHIV-CN97001: a replication-competent, R5 simian/human immunodeficiency virus containing env of a primary Chinese HIV-1 clade C isolate.Intranasal Vaccination Affords Localization and Persistence of Antigen-Specific CD8⁺ T Lymphocytes in the Female Reproductive Tract.Intranasal immunization with a helper-dependent adenoviral vector expressing the codon-optimized fusion glycoprotein of human respiratory syncytial virus elicits protective immunity in BALB/c mice.Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV.Helper-Dependent Adenoviral Vectors.Advances and future challenges in adenoviral vector pharmacology and targeting.Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives.Comparison of the Life Cycles of Genetically Distant Species C and Species D Human Adenoviruses Ad6 and Ad26 in Human Cells.Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models.Lessons on Non-Progression of HIV Disease from Monkeys.High-capacity adenoviral vectors circumvent the limitations of ΔE1 and ΔE1/ΔE3 adenovirus vectors to induce multispecific transgene product-directed CD8 T-cell responses.Single-cycle adenovirus vectors in the current vaccine landscape.
P2860
Q34033882-5CB5DA59-F84F-44A2-BD41-9E92D5AB6154Q34502108-E49CE3EE-D0EC-4811-BDF8-77B34E9DC085Q34669375-1CB88DCC-BE6D-422E-A793-88FF02C143C8Q34781602-C988D913-7C7D-49C2-BDBE-4380FAB87085Q35115599-8A9DD1CD-F16E-41E8-879F-80590AFE3769Q36073984-DE1C6842-FFF1-4D0E-8054-542EB43D0AB9Q36735275-8C917829-3C19-40D1-BE9F-B94341BFC6DBQ36937656-B5FB21A9-343F-43BF-B49F-67329498230EQ36981370-250E1DF0-23A6-4A57-8F4B-A439200EC9FDQ37582126-23E71263-E921-4CB4-9514-7A15E76E487EQ37859842-964801B7-5ED7-4B59-9D9F-F385EBC7BE9FQ37945218-7626A769-AF3C-43A8-91AE-38DF222E4518Q38831184-626C59BA-942E-4939-80F1-3796B893C5C2Q39358889-9035D0E8-8EBB-48F0-89AC-E99FC58A3C80Q41214512-C7ED9B9F-BC05-49D1-9E1B-67AF738EE094Q45875102-0953D342-4301-4BBE-94E8-F6D5BF145294Q47282517-449BC02D-E30E-49A6-BE91-913914B2EBC7
P2860
Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus Vaccines
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Protection against Mucosal SHI ...... -Dependent Adenovirus Vaccines
@en
Protection against Mucosal SHI ...... Dependent Adenovirus Vaccines.
@nl
type
label
Protection against Mucosal SHI ...... -Dependent Adenovirus Vaccines
@en
Protection against Mucosal SHI ...... Dependent Adenovirus Vaccines.
@nl
prefLabel
Protection against Mucosal SHI ...... -Dependent Adenovirus Vaccines
@en
Protection against Mucosal SHI ...... Dependent Adenovirus Vaccines.
@nl
P2093
P2860
P356
P1433
P1476
Protection against Mucosal SHI ...... -Dependent Adenovirus Vaccines
@en
P2093
Bharti P Nehete
Donna Palmer
Eric A Weaver
K Jagannadha Sastry
Michael A Barry
Pramod N Nehete
Stephanie J Buchl
P2860
P356
10.3390/V1030920
P577
2009-12-01T00:00:00Z